Citations
669 citation(s) found for "Patnaik, Mrinal".
TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome
Sharplin, Kirsty, Chhetri, Rakchha , Ladon, Dariusz, Al‐Kali, Aref , Litzow, Mark R. , Mangaonkar, Abhishek A. , Gangat, Naseema , Patnaik, Mrinal M. , Begna, Kebede, Tefferi, Ayalew , Shah, Meera , Hahn, Christopher N , Tran, Elizabeth Ngoc Hoa , Baranwal, Anmol , Kutyna, Monika , Wang, Paul Po-Shen , Alkhateeb, Hassan B. , Ross, David M , Yeung, David , Shanmuganathan, Naranie , Hogan, William J. , Kumar, Sharad , Singhal, Deepak , Brown, Anna , Scott, Hamish S. , THOMAS, DANIEL W. , Kok, Chung Hoow , Hiwase, Devendra
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9798-9799
Clonal Hematopoiesis in Vexas Syndrome
Gutierrez‐Rodrigues, Fernanda , Kusne, Yael , Fernandez, Jenna A., Ma, Xiaoyang , Alessi, Hugh, Finke, Christy M. , Mangaonkar, Abhishek A. , Begna, Kebede H. , Viswanatha, David S., Wilson, Lorena, Kourelis, Taxiarchis , Reichard, Kaaren K. , Olteanu, Horatiu , Darden, Ivana, Hironaka, Dalton, Rosenzweig, Sofia , Kastner, Daniel L. , Grayson, Peter C. , Beck, David B. , Patnaik, Mrinal M. , Young, Neal S. , Patel, Bhavisha A. , Lasho, Terra L. , Shalhoub, Ruba N. , Koster, Matthew J. , Warrington, Kenneth J. , Xie, Zhuoer , Ombrello, Amanda K. , Ferrada, Marcela A. , Go, Ronald S. , Groarke, Emma M , Calvo, Katherine R. , Wu, Colin O.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 5745-5746
Characteristics and Outcomes of Radiation Therapy-Related Myeloid Neoplasms
Shultz, Carl , Al‐Kali, Aref , Chhetri, Rakchha , Arsana, Arini, Stish, Bradley J. , Tefferi, Ayalew , Patnaik, Mrinal M. , Gangat, Naseema , Baranwal, Anmol , Tran, Elizabeth Ngoc Hoa , Alkhateeb, Hassan B. , Hiwase, Devendra , Shah, Meera
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6309-6311
Venetoclax Plus Hypomethylating Agent (HMA) Based Induction for Treatment-Naive Older/Unfit Patients with FLT3-Mutated Acute Myeloid Leukemia (AML)
Ghorab, Ahmad , Litzow, Mark R. , Gangat, Naseema , Al‐Kali, Aref , Tefferi, Ayalew , Begna, Kebede H. , Patnaik, Mrinal M. , Foran, James M. , Ghorab, Ahmad , Shah, Meera , Murthy, Hemant S. , Alkhateeb, Hassan B. , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9019-9020
Outcome of Patients with Acute Myeloid Leukemia Following Failure of Front-Line Venetoclax Plus Hypomethylating Agent Therapy
Ilyas, Rimal, Johnson, Isla McKerrow , Al‐Kali, Aref , Begna, Kebede, Mangaonkar, Abhishek A. , Litzow, Mark R. , Patnaik, Mrinal M. , Pardanani, Animesh , Tefferi, Ayalew, Gangat, Naseema , McCullough, Kristen , Alkhateeb, Hassan B. , Hogan, William J. , Shah, Meera , Tefferi, Ayalew
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1286-1287
Genomic and Transcriptional Profiling Stratifies Vq Myeloma Lines into Two Clusters with Distinct Risk Signatures and Drug Responses
Flietner, Evan, Yu, Mei , Zhou, Yun , Feng, Yubin, Wen, Zhi , Sun, Yuqian, Burns, Robert, Patnaik, Mrinal M. , Asimakopoulos, Fotis , Zhang, Jing , Rajagopalan, Adhithi , Veltri, Anthony J. , Lasho, Terra L. , Callander, Natalie S. , Wang, Demin
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9935-9936
Response Rates to Venetoclax Based Therapies in Chronic Phase and Blast Transformed Chronic Myelomonocytic Leukemia
Litzow, Mark R. , Gangat, Naseema , Al‐Kali, Aref , Foran, James M. , Palmer, Jeanne , Mangaonkar, Abhishek A. , McCullough, Kirsten, Tefferi, Ayalew , Patnaik, Mrinal M. , Csizmar, Clifford M. , Saliba, Antoine N. , Hogan, William J. , McCullough, Kirsten, Alkhateeb, Hassan B.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12238-12240
The Characteristics and Prognosis of Patients with Clonal Cytopenias of Undetermined Significance, Including Cancer and Therapy-Related Clonal Cytopenias
Smith, Alexandra N., Ali, Najla Al , Coombs, Catherine C. , Foran, James M. , Tsai, Charlton , Amanam, Idoroenyi , Lai, Catherine , Deeg, Joachim, Dinner, Shira, Chandhok, Namrata S. , Soong, Deborah, Brunner, Andrew M. , Geyer, Susan M. , Padron, Eric , Patnaik, Mrinal M. , Al‐Kali, Aref , Xie, Zhuoer , Komrokji, Rami S. , Patel, Anand , Saygin, Caner , Zeidan, Amer M. , Bewersdorf, Jan Philipp , Kishtagari, Ashwin , Zeidner, Joshua F. , Madanat, Yazan F. , Badar, Talha , Desai, Pinkal , Griffiths, Elizabeth A. , Malki, Monzr M. Al , Lai, Catherine, Adès, Lionel , Yi, Cecilia Arana , Osman, Afaf E.G. , Abaza, Yasmin , Taylor, Justin , Carraway, Hetty E. , Singh, Abhay , Savona, Michael R.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2887-2890
Phase II Study Assessing Safety and Preliminary Efficacy of High Dose Intravenous Ascorbic Acid in Patients with TET2 Mutant Clonal Cytopenias of Undetermined Significance
Finke, Christy M. , Amundson, Michelle Renee, LaPlant, Betsy, Mangaonkar, Abhishek A. , Gangat, Naseema , Reichard, Kaaren K. , Elliott, Michelle A. , Patnaik, Mrinal M. , Xie, Zhuoer , McCullough, Kristen , Lasho, Terra L. , Fernandez, Jenna , Witzig, Thomas E.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2893-2894
Leukemic Transformation of Myeloproliferative Neoplasms in the Post-Ruxolitinib Era: Analysis of 103 Consecutive Cases Diagnosed 2011-2021
Abdelmagid, Maymona, Al‐Kali, Aref , Begna, Kebede H. , Litzow, Mark R. , Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Elliott, Michelle A. , Howard, Matthew O. , Reichard, Kaaren K. , Pardanani, Animesh , Gangat, Naseema , Tefferi, Ayalew , Hogan, William J. , Alkhateeb, Hassan B. , Shi, Min , Howard, Matthew, Ketterling, Rhett P.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9735-9736